Philippe Mellet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Philippe Mellet has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Sylvain R. A. Marque
“Ilie Murgulescu” Institute of Physical Chemistry of the Romanian Academy, 202 Splaiul Independentei, Bucharest 060021, Romania
16 shared publications - Gérard Audran
Aix-Marseille University, CNRS, UMR 7273, Case 551, Avenue Escadrille Normandie-Niemen, CEDEX 20, 13397 Marseille, France
12 shared publications Natacha Jugniot
Univ. Bordeaux, CNRS, CRMSB UMR 5536, F-33000 Bordeaux, France
6 shared publications- Nicolas Vanthuyne
FSCM Aix Marseille Univ, CNRS, Centrale Med Marseille France
6 shared publications Pierre Voisin
Bordeaux University, CNRS, RMBS-UMR 5536
6 shared publicationsPhilippe Massot
Magnetic Resonance of Biological Systems, UMR 5536 CNRS-University of Bordeaux, Bordeaux, France
5 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Springer Nature in BMC Research Notes
Elastin peptides elicited during acute lung inflammation detected in gall bladder by elastase-sensitive Overhauser-enhanced MRI
- 10 November 2026
- Published by Springer Nature in BMC Research Notes
Open AccessElastin peptides elicited during acute lung inflammation detected in gall bladder by elastase-sensitive Overhauser-enhanced MRI
- 3 August 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (15) , 18915-18921
Homolysis of Alkoxyamines Triggered by Carbohydrate-Active Enzyme: A Step toward a General Platform to Generate Toxic Alkyl Radicals
The rise of drug-resistant pathogens and the dose-limiting side effects of current therapies highlight the urgent need for innovative treatment strategies. We recently demonstrated that hybrid alkoxyamine–peptide conjugates, upon enzymatic cleavage by specific peptidases, undergo C–O bond homolysis to generate highly reactive radical species capable of inducing broad-spectrum damage to pathogenic organisms (cancerous cells, parasites, fungi, etc.). Relying on this concept, we now report on the design and synthesis of a new class of enzyme-triggered, releasing radical prodrugs with a carbohydrate structure as a leaving group. These molecules offer a versatile strategy for the development of next-generation therapeutics that couple enzymatic specificity using glucosidase with controlled radical release to fight resistant and difficult-to-treat infections.
- 3 August 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (15) , 18915-18921
Homolysis of Alkoxyamines Triggered by Carbohydrate-Active Enzyme: A Step toward a General Platform to Generate Toxic Alkyl Radicals
The rise of drug-resistant pathogens and the dose-limiting side effects of current therapies highlight the urgent need for innovative treatment strategies. We recently demonstrated that hybrid alkoxyamine–peptide conjugates, upon enzymatic cleavage by specific peptidases, undergo C–O bond homolysis to generate highly reactive radical species capable of inducing broad-spectrum damage to pathogenic organisms (cancerous cells, parasites, fungi, etc.). Relying on this concept, we now report on the design and synthesis of a new class of enzyme-triggered, releasing radical prodrugs with a carbohydrate structure as a leaving group. These molecules offer a versatile strategy for the development of next-generation therapeutics that couple enzymatic specificity using glucosidase with controlled radical release to fight resistant and difficult-to-treat infections.
- Open Access
- 3 August 2026
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 50 (30) , 12381-12385
Nitroreductases as alkoxyamine-selective triggers
Nitroreductase-mediated alkoxyamine activation: a selective approach for prodrugs.
- 3 August 2026
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 50 (30) , 12381-12385
Open AccessNitroreductases as alkoxyamine-selective triggers
Nitroreductase-mediated alkoxyamine activation: a selective approach for prodrugs.
- Open Access
Correction: Embo-Ibouanga et al. Peptide-Alkoxyamine Drugs: An Innovative Approach to Fight Schistosomiasis: “Digging Their Graves with Their Forks”. Pathogens 2024, 13, 482
There was an error in the original publication
Open AccessCorrection: Embo-Ibouanga et al. Peptide-Alkoxyamine Drugs: An Innovative Approach to Fight Schistosomiasis: “Digging Their Graves with Their Forks”. Pathogens 2024, 13, 482
There was an error in the original publication
- Open Access
- 4 July 2025
- Published by MDPI AG in Journal of Fungi
- Vol. 11 (7) , 503
Pathogen Enzyme-Mediated Alkoxyamine Homolysis as a Killing Mechanism of Aspergillus fumigatus
The emergence of antifungal-resistant Aspergillus fumigatus (A. fumigatus) became a serious public health concern, underscoring the need for new effective antifungal agents. Here, we present a strategy based on the in situ generation of radical species that are toxic to the pathogen. The synthesis of an alkoxyamine linked to a peptide substrate recognized by A. fumigatus-secreted dipeptidyl peptidase is described. Kinetic experiments show a stable prodrug prior to enzymatic activation. Ensuing peptide cleavage and spontaneous homolysis resulted in the generation of a stable nitroxide and a reactive alkyl radical moiety. Next, the exposure of A. fumigatus spores to the prodrug lead to pathogen growth inhibition in a compound concentration-dependent fashion (e.g., 42% inhibition at 10 µg/L). Importantly, the designed alkoxyamine inhibited not only the growth of a clinical voriconazole-susceptible A. fumigatus strain, but also the growth of a strain resistant to this azole. To determine the antifungal importance of the reactive alkyl radical, its substitution with a non-radical structure did not prevent A. fumigatus growth. Furthermore, the introduction of succinic group in the peptide substrate resulted in the loss of alkoxyamine antifungal properties. Our work reports a novel chemical strategy for antifungal therapy against A. fumigatus based on the pathogen enzyme-mediated generation of toxic radicals. Significantly, these findings are timely since they could overcome the emerged resistance to conventional drugs that are known to target defined pathogen biologic mechanisms such as ergosterol synthesis.
- 4 July 2025
- Published by MDPI AG in Journal of Fungi
- Vol. 11 (7) , 503
Open AccessPathogen Enzyme-Mediated Alkoxyamine Homolysis as a Killing Mechanism of Aspergillus fumigatus
The emergence of antifungal-resistant Aspergillus fumigatus (A. fumigatus) became a serious public health concern, underscoring the need for new effective antifungal agents. Here, we present a strategy based on the in situ generation of radical species that are toxic to the pathogen. The synthesis of an alkoxyamine linked to a peptide substrate recognized by A. fumigatus-secreted dipeptidyl peptidase is described. Kinetic experiments show a stable prodrug prior to enzymatic activation. Ensuing peptide cleavage and spontaneous homolysis resulted in the generation of a stable nitroxide and a reactive alkyl radical moiety. Next, the exposure of A. fumigatus spores to the prodrug lead to pathogen growth inhibition in a compound concentration-dependent fashion (e.g., 42% inhibition at 10 µg/L). Importantly, the designed alkoxyamine inhibited not only the growth of a clinical voriconazole-susceptible A. fumigatus strain, but also the growth of a strain resistant to this azole. To determine the antifungal importance of the reactive alkyl radical, its substitution with a non-radical structure did not prevent A. fumigatus growth. Furthermore, the introduction of succinic group in the peptide substrate resulted in the loss of alkoxyamine antifungal properties. Our work reports a novel chemical strategy for antifungal therapy against A. fumigatus based on the pathogen enzyme-mediated generation of toxic radicals. Significantly, these findings are timely since they could overcome the emerged resistance to conventional drugs that are known to target defined pathogen biologic mechanisms such as ergosterol synthesis.
- 11 February 2025
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 41 (7) , 4862-4873
Tailoring Nanodiamonds for High-Contrast EPR Imaging: Size, Surface Properties, and Spectroscopic Performance
Electron paramagnetic resonance (EPR) spectroscopy is a tool that provides sensitive detection of uncoupled electron spins for a variety of applications. This technique enables the specific detection and quantification of radical species while also being able of generating high-contrast, background-free images. However, the EPR labeling and imaging techniques encounter limitations mainly due to the instability of organic radicals from organic probes, which can influence the reliability and scope of the experiment. In that context, the use of nanodiamonds (NDs) in EPR may be a promising route for understanding their unique properties and potential biomedical applications. The ability to perform EPR imaging in combination with the stable intrinsic properties of paramagnetic centers within these particles raises the possibility of extending nanodiamond-based imaging capabilities. Herein, we present a preliminary demonstration of a practical spectroscopy and imaging application using nanosized diamond particles (R < 1 mm) as well as achievable EPR sensitivity.
- 11 February 2025
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 41 (7) , 4862-4873
Tailoring Nanodiamonds for High-Contrast EPR Imaging: Size, Surface Properties, and Spectroscopic Performance
Electron paramagnetic resonance (EPR) spectroscopy is a tool that provides sensitive detection of uncoupled electron spins for a variety of applications. This technique enables the specific detection and quantification of radical species while also being able of generating high-contrast, background-free images. However, the EPR labeling and imaging techniques encounter limitations mainly due to the instability of organic radicals from organic probes, which can influence the reliability and scope of the experiment. In that context, the use of nanodiamonds (NDs) in EPR may be a promising route for understanding their unique properties and potential biomedical applications. The ability to perform EPR imaging in combination with the stable intrinsic properties of paramagnetic centers within these particles raises the possibility of extending nanodiamond-based imaging capabilities. Herein, we present a preliminary demonstration of a practical spectroscopy and imaging application using nanosized diamond particles (R < 1 mm) as well as achievable EPR sensitivity.
- 3 December 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 23 (3) , 734-743
Dynamic covalent bonding (DCB): the bond lability of alkoxyamines as drugs against Schistosoma mansoni and Plasmodium falciparum
To dig its grave with its fork : How feeding Plasmodium and Schistosoma with hybrid peptide-alkoxyamines that release reactive radicals in the presence of enzymatic activities leads to their death.
- 3 December 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 23 (3) , 734-743
Dynamic covalent bonding (DCB): the bond lability of alkoxyamines as drugs against Schistosoma mansoni and Plasmodium falciparum
To dig its grave with its fork : How feeding Plasmodium and Schistosoma with hybrid peptide-alkoxyamines that release reactive radicals in the presence of enzymatic activities leads to their death.
- Open Access
- 30 October 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 12 (42) , 10923-10933
A radical containing micellar probe for assessing esterase enzymatic activity with ultra-low field Overhauser-enhanced magnetic resonance imaging
In this study, we propose the use of an off/on probe, T2C 12 –T80, to monitor esterase activity in various cancer cell lines with Overhauser-MRI at an ultra-low field (206 μT), proving its sensitivity and suitability for in vivo translation.
- 30 October 2024
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 12 (42) , 10923-10933
Open AccessA radical containing micellar probe for assessing esterase enzymatic activity with ultra-low field Overhauser-enhanced magnetic resonance imaging
In this study, we propose the use of an off/on probe, T2C 12 –T80, to monitor esterase activity in various cancer cell lines with Overhauser-MRI at an ultra-low field (206 μT), proving its sensitivity and suitability for in vivo translation.
- Open Access
- 5 September 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (37) , 39004-39012
Intrinsic Proteolytic Activities from Cancer Cells Are Sufficient to Activate Alkoxyamine Prodrugs and Induce Cell Death
In search of better specificity and lower chances of resistance, protease-activatable alkoxyamine prodrugs to fight cancer have been proposed. These molecules are made of a peptide linked to an alkoxyamine. Proteolysis of the peptide converts the stable prodrug at 37 °C to a metastable alkoxyamine that spontaneously homolyzes into two free radicals: a stable nitroxide and a very reactive alkyl radical. The alkyl radical induces apoptosis in the surrounding cells by inducing random chemical alterations. Here, we show that varying the peptide moiety from succinyl-Ala-Ala-Pro-Val- to PyroGlu-Gly-Arg- or PyroGlu-Gly-Lys- is effective in switching the activating enzyme from elastase to urokinase. Furthermore, these prodrugs induce the death of HT-1080 cells, a cell line that secretes several active proteases in culture. This cytotoxic activity can be suppressed by protease inhibitors and does not affect cell lines devoid of active urokinase. We thus provide examples of alkoxyamine prodrugs that are efficiently activated by the limited intrinsic protease activity and that succeed in the destruction of cancer cell lines and cancer cells from tumor explants.
- 5 September 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (37) , 39004-39012
Open AccessIntrinsic Proteolytic Activities from Cancer Cells Are Sufficient to Activate Alkoxyamine Prodrugs and Induce Cell Death
In search of better specificity and lower chances of resistance, protease-activatable alkoxyamine prodrugs to fight cancer have been proposed. These molecules are made of a peptide linked to an alkoxyamine. Proteolysis of the peptide converts the stable prodrug at 37 °C to a metastable alkoxyamine that spontaneously homolyzes into two free radicals: a stable nitroxide and a very reactive alkyl radical. The alkyl radical induces apoptosis in the surrounding cells by inducing random chemical alterations. Here, we show that varying the peptide moiety from succinyl-Ala-Ala-Pro-Val- to PyroGlu-Gly-Arg- or PyroGlu-Gly-Lys- is effective in switching the activating enzyme from elastase to urokinase. Furthermore, these prodrugs induce the death of HT-1080 cells, a cell line that secretes several active proteases in culture. This cytotoxic activity can be suppressed by protease inhibitors and does not affect cell lines devoid of active urokinase. We thus provide examples of alkoxyamine prodrugs that are efficiently activated by the limited intrinsic protease activity and that succeed in the destruction of cancer cell lines and cancer cells from tumor explants.
- Open Access
Peptide-Alkoxyamine Drugs: An Innovative Approach to Fight Schistosomiasis: “Digging Their Graves with Their Forks”
The expansion of drug resistant parasites sheds a serious concern on several neglected parasitic diseases. Our recent results on cancer led us to envision the use of peptide-alkoxyamines as a highly selective and efficient new drug against schistosome adult worms, the etiological agents of schistosomiasis. Indeed, the peptide tag of the hybrid compounds can be hydrolyzed by worm’s digestive enzymes to afford a highly labile alkoxyamine which homolyzes spontaneously and instantaneously into radicals—which are then used as a drug against Schistosome adult parasites. This approach is nicely summarized as digging their graves with their forks. Several hybrid peptide-alkoxyamines were prepared and clearly showed an activity: two of the tested compounds kill 50% of the parasites in two hours at a concentration of 100 µg/mL. Importantly, the peptide and alkoxyamine fragments that are unable to generate alkyl radicals display no activity. This strong evidence validates the proposed mechanism: a specific activation of the prodrugs by the parasite proteases leading to parasite death through in situ alkyl radical generation.
Open AccessPeptide-Alkoxyamine Drugs: An Innovative Approach to Fight Schistosomiasis: “Digging Their Graves with Their Forks”
The expansion of drug resistant parasites sheds a serious concern on several neglected parasitic diseases. Our recent results on cancer led us to envision the use of peptide-alkoxyamines as a highly selective and efficient new drug against schistosome adult worms, the etiological agents of schistosomiasis. Indeed, the peptide tag of the hybrid compounds can be hydrolyzed by worm’s digestive enzymes to afford a highly labile alkoxyamine which homolyzes spontaneously and instantaneously into radicals—which are then used as a drug against Schistosome adult parasites. This approach is nicely summarized as digging their graves with their forks. Several hybrid peptide-alkoxyamines were prepared and clearly showed an activity: two of the tested compounds kill 50% of the parasites in two hours at a concentration of 100 µg/mL. Importantly, the peptide and alkoxyamine fragments that are unable to generate alkyl radicals display no activity. This strong evidence validates the proposed mechanism: a specific activation of the prodrugs by the parasite proteases leading to parasite death through in situ alkyl radical generation.